IGF London 2025 brought together influential leaders, policymakers, and innovators to explore how the recently announced deal between the UK and India can unlock the next decade of collaboration. From digital trade, sustainable finance, frontier tech and regulation for inclusive growth, to ways to implement mutually beneficial programmes. BIVDA took part in discussions in the UK-India Future Frontiers Forum at…
Ben KempJune 25, 2025
Greater genetic diversity needed to widen genomics benefits in cancer care Greater diversity is needed in genetic research to make genomics’ use in cancer care and screening more accurate and reliable for all, according to a new study. The research, led by Genomics England and published in The Lancet Oncology, analysed the data of over 14,000 participants with cancer…
Ben KempJune 25, 2025
In the latest of their key plans, the Government have released their industrial strategy. BIVDA look into the details behind the headlines. As set out previously in our report on the spending review, the not-so-new Government needs desperately to drive economic growth. The three biggest barriers to their re-election are concerns around immigration, NHS performance, and the UK economy. With…
Ben KempJune 24, 2025
The UK Government's Spending Review 2025, outlined significant investments in health and science, aiming to address longstanding challenges with the UK’s health and wealth. But what lies below the headlines? BIVDA’s Director of Policy and Programmes, Paul Fisher, looks deeper. The government is in an invidious position. With a moribund economy and a significant proportion of the population economically inactive…
Ben KempJune 24, 2025
Last week, the government released their Infrastructure Strategy, one of the first in the flurry of plans set to affect our industry over the next few weeks. The government has framed this as a transformative strategy aimed at renewing the UK's infrastructure and reversing over a decade of decline. The plan is backed by at least £725 billion of government…
Ben KempJune 24, 2025
Join BIVDA's next Near Patient Testing Working Party meeting on Thursday 3rd July, 2pm - 4.30pm at our offices. We will be moving to a new, exciting format for our next NPT meeting to encourage discussions and conversations. Near Patient Testing - Actionable Steps towards the challenges of NPT Together we want to create actionable steps towards the challenges that we face…
Ben KempJune 24, 2025
Registration for the 2025 Standardisation of Genome Amplification Techniques and Serology (SoGATS) Workshop to be held on 24 - 26 September 2025 is now open. The Workshop will be held at the Medicines and Healthcare products Regulatory Agency (MHRA) Science Campus, Blanche Lane, South Mimms, Potters Bar, Hertfordshire EN6 3QG, UK. Please note that this will be a hybrid…
Ben KempJune 24, 2025
The European Commission has published the Final Summary Report of its Targeted Evaluation of the EU Medical Devices and In Vitro Diagnostic Regulations (MDR/IVDR). Early analysis by MedTech Europe has shown the following: Reforms should prioritise simplification, a risk-based and proportionate approach, and clearer guidance to enhance implementation. There is support for harmonised EU regulations; however, compliance costs remain…
Ben KempJune 24, 2025
On a recent trip to Washington D.C., the Chief Executive of the MHRA Lawrence Tallon outlined the agency's strategic direction. Mr Tallon stated his intention to build a world-class safety and surveillance system enabled by comprehensive real-world data for the protection of patients and the public. In line with BIVDA's priorities, he also signalled that the agency seeks to…
Ben KempJune 24, 2025